Tilray Brands, Inc. Business Acquisition, Pro Forma Net Income (Loss)
Tilray Brands, Inc. (TLRY) reported Business Acquisition, Pro Forma Net Income (Loss) of -$5.50 million for the 13-month period ending 2025-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2026-07-28
- Tilray Brands, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2023-02-28 was $600.00K.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 13 month |
|---|---|---|---|
| 2025-05-31 | -$5.50M 10-K · filed 2026-07-28 | ||
| 2023-02-28 | $600.00K 10-Q · filed 2024-04-09 | $1.80M 10-Q · filed 2024-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |